🔗 Share this article

The top legal official in Texas Ken Paxton is suing the manufacturers of acetaminophen, asserting the companies withheld potential risks that the medication posed to children's cognitive development.

The court filing comes a month after Former President Trump promoted an unsubstantiated connection between taking acetaminophen - referred to as paracetamol - during pregnancy and autism spectrum disorder in young ones.

Paxton is taking legal action against Johnson & Johnson, which once produced the drug, the sole analgesic suggested for women during pregnancy, and Kenvue, which currently produces it.

In a declaration, he stated they "betrayed America by making money from discomfort and marketing drugs without regard for the dangers."

The company states there is insufficient reliable data tying Tylenol to autism.

"These corporations misled for generations, intentionally threatening countless individuals to increase profits," Paxton, from the Republican party, said.

Kenvue stated officially that it was "seriously troubled by the perpetuation of misinformation on the security of acetaminophen and the possible consequences that could have on the welfare of US mothers and children."

On its official site, the company also stated it had "continuously evaluated the relevant science and there is insufficient valid information that indicates a verified association between using acetaminophen and autism."

Organizations representing medical professionals and medical practitioners agree.

The leading OB-GYN organization has declared acetaminophen - the main ingredient in acetaminophen - is among limited choices for pregnant women to manage discomfort and elevated temperature, which can present major wellness concerns if ignored.

"In multiple decades of studies on the use of paracetamol in gestation, zero credible investigations has definitively established that the consumption of paracetamol in any stage of gestation results in neurodevelopmental disorders in young ones," the organization commented.

This legal action mentions recent announcements from the former administration in arguing the medication is reportedly hazardous.

Last month, Trump generated worry from public health officials when he advised women during pregnancy to "resist strongly" not to take Tylenol when ill.

The FDA then issued a notice that doctors should think about restricting the use of acetaminophen, while also stating that "a causal relationship" between the medication and autism in young ones has remains unverified.

Health Secretary Kennedy, who oversees the Food and Drug Administration, had vowed in April to conduct "comprehensive study program" that would identify the source of autism in a limited time.

But specialists warned that finding a unique factor of autism spectrum disorder - considered by experts to be the result of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism is a form of lifelong neurodivergence and condition that affects how individuals perceive and relate to the environment, and is identified using doctors' observations.

In his legal document, the attorney general - aligned with the former president who is seeking US Senate - claims the manufacturer and Johnson & Johnson "intentionally overlooked and attempted to silence the science" around acetaminophen and autism.

This legal action aims to force the firms "remove any commercial messaging" that claims Tylenol is secure for expectant mothers.

The court case echoes the grievances of a group of mothers and fathers of minors with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in two years ago.

Judicial authorities rejected the lawsuit, stating research from the plaintiffs' authorities was inconclusive.